Data / Form D filings / TRANSAVE INC
TRANSAVE INC: Form D filings
TRANSAVE INC, a biotechnology company in Monmouth Jct., NJ, filed 3 Form D notices with the SEC between 2009 and 2010. The latest, on September 28, 2010, reports $2 million sold of a $6 million offering.
Find out what TRANSAVE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11 DEER PARK DRIVE, SUITE 117, Monmouth Jct., NJ, 08852
- Phone
- (732) 438-9434
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1118616
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 28, 2010 | New notice | $6,000,000 | $2,000,000 | $4,000,000 | 0 | Sep 17, 2010 | sec.gov |
| Jun 25, 2010 | New notice | $5,855,619 | $5,499,999 | $355,620 | 0 | Jun 16, 2010 | sec.gov |
| Nov 3, 2009 | New notice | $12,000,000 | $5,542,573 | $6,457,427 | 0 | Oct 26, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Donald Hayden, Jr. | Director | |
| Nicholas H.C. Gurreri | Executive Officer | |
| Mark G. Cipriano | Director | |
| Alex Barkas | Director | |
| Robert H.C. Weisskoff | Director | |
| Michio Soga | Executive Officer | |
| Richard S. Kollender | Director | |
| Timothy Whitten | Executive Officer, Director | |
| Walter Perkins | Executive Officer | |
| Renu Gupta | Executive Officer | |
| Stephen H.C. Kraus | Director | |
| Geert-Jan H.C. Mulder | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Sep 27, 2010 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TRANSAVE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.